pharma
Novartis’ Adakveo becomes first FDA-approved P-selectin inhibitor for sickle cell disease
November 18, 2019Sales and Marketing Adakve, Novartis, pharma, sickle cell disease
The FDA has chosen to award Novartis’ Adakveo (crizanlizumab) with marketing authorisation, it has emerged, as a treatment to reduce …
Over half of all anti-vaccine ads on Facebook stem from just two advertisers
November 15, 2019Medical Communications, Research and Development Facebook, anti-vaccine, pharma
A new study has revealed that the largest share of anti-vaccine advertisements on Facebook originate from just two organisations, both …
AstraZeneca’s Qtrilment scores European authorisation in type 2 diabetes
November 15, 2019Medical Communications, Sales and Marketing AstraZeneca, EU, Europe, Qtrilmet, diabetes, pharma, type 2 diabetes
Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) has secured approval in Europe, its manufacturer AstraZeneca has revealed, as a therapy to …
New report reveals shocking knowledge gaps around type 2 diabetes risk factors
November 14, 2019Medical Communications, Research and Development Merck KGaA, diabetes, pharma, type 2 diabetes
A new report released on World Diabetes Day has shone a light on a startling lack of knowledge surrounding type …
FDA advisory committee votes down approval of Boehringer and Lilly’s drug for type 1 diabetes
November 14, 2019Sales and Marketing Boehringer Ingelheim, Eli Lilly, empagliflozin, jardiance, pharma
Boehringer Ingelheim and Eli Lilly’s have been dealt a blow from the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC), …
Myeloma UK reveals new Director of Research appointment
November 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Myleoma UK, appointment, multiple myeloma, pharma
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, who in her new role …
NICE greenlights Consilient Health’s Elmiron for bladder pain syndrome
November 14, 2019Sales and Marketing NICE, consilient health, elmiron, pharma
NICE has chosen to recommend Consilient Health’s Elmiron (pentosan polysulfate sodium) for the treatment of bladder pain syndrome (BPS), it …
MSD’s proposed sale of French manufacturing plant puts over 200 jobs in jeopardy
November 14, 2019Manufacturing and Production France, MSD, pharma
MSD has announced its plans to put its Centre de Mirabel production facility in Riom, France up for sale – …
Vertex’s cystic fibrosis portfolio to be made available across Northern Ireland and Wales
November 13, 2019Research and Development, Sales and Marketing Kalydeco, NHS, Orkambi, Symkevi, Vertex, pharma
After drawn out negotiations and much discontent among cystic fibrosis (CF) patients and their advocates, Vertex has announced that a …
Mylan and Upjohn merger will create a new entity: Viatris
November 13, 2019Manufacturing and Production, Research and Development, Sales and Marketing Mylan, Pfizer, Upjohn, Viatris, pharma
The name for the new company emerging out of the merger between Pharma firm Mylan and Pfizer division Upjohn has …
GSK’s Nucala meets Phase 3 goal in reducing hypereosinophilic syndrome flare-ups
November 13, 2019Research and Development GSK, Nucala, pharma
GlaxoSmithKline has unveiled new Phase 3 data for its IL-5 inhibitor Nucala (mepolizumab), revealing that the therapy met its primary …
Pfizer’s tofacitinib hits main goal in Phase 3 juvenile idiopathic arthritis study
November 12, 2019Manufacturing and Production, Research and Development Pfizer, pharma, tofacitinib
Pfizer has lifted the lid on new Phase 3 data exploring the efficacy of tofacitinib in the treatment of juvenile …
Scottish Medicines Consortium recommends Eisai’s Kisplyx for advanced kidney cancer
November 12, 2019Manufacturing and Production, Sales and Marketing Eisai, Kisplyx, NHS, Sotland, pharma
Eisai’s Kisplyx (lenvatinib) has secured recommendation from the Scottish Medicines Consortium, it has been revealed, meaning that patients on the …
MSD secures EU approval for its Zaire Ebola vaccine Ervebo
November 12, 2019Manufacturing and Production, Sales and Marketing Ebola, Ervebo, MSD, pharma
MSD has scored approval from the European Commission for Ervebo, the company’s Zaire Ebola vaccine, for the prevention of Ebola …
Novartis’ Kisqali approved for NHS Scotland in most common advanced breast cancer
November 12, 2019Manufacturing and Production, Sales and Marketing Cancer, Kisqali, NHS, Novartis, Scotland, breast cancer, pharma
NHS patients in Scotland will soon be able to access Novartis’ CDK4/6 inhibitor Kisqali (ribociclib) after the Scottish Medicines Consortium …
Latest content
Five Facts about cardiovascular disease
